期刊文献+

急性出血性脑血管病临床诊治分析 被引量:4

Analysis of clinical diagnosis and treatment in acute hemorrhagic cerebrovascular disease
原文传递
导出
摘要 目的:探讨急性出血性脑血管疾病的临床治疗方法,并观察和分析其临床效果及应用价值.方法:回顾性分析100例急性出血性脑血管疾病患者的一般资料,按照自愿、对照的原则分为观察组和对照组,各为50例.两组疗程均为2个月,对照组采用常规的治疗方法,即以甘露醇、速尿、能量合剂等药物脱水降颅压、保护脑组织.观察组在对照组的基础上,加用血塞通注射液400mg静脉点滴,每日1次.观察和比较两组患者临床治疗有效率和并发症的发生情况.结果:观察组临床治疗总有效率为96 0%,对照组临床治疗总有效率为80.0%,两组比较,观察组治疗效果明显优于对照组,差异具有统计学意义(P〈0.05);观察组出现1例并发症,占2.0%,对照组出现8例并发症,占16.0%,两组比较,观察组并发症发生率明显低于对照组,差异具有统计学意义(P〈0.05).结论:临床采用血塞通注射液治疗急性出血性脑血管疾病效果显著,且并发症较少,能明显的改善患者的病情和预后,提高患者的生存质量和生活质量,值得临床进一步推广应用. Objective :To investigate clinical treatments of acute hemorrhagic cerebrovascular disease, observe its clinical effects and analyze its applicative value. Methods: Retrospectively analyse the general information of 100 cases of acute hemorrhagic cerebrovascular disease and divide them into the observe group and the control group, each of 50 cases, on a voluntary and control basis. The treatment lasted 2 months in both groups. Conventional treatments are used in the control group including drugs such as mannitol, furosemide and energy mixture for reducing intracranial pressure by dehydration and protecting the brain tissue. Based on the treatment of the control group, the observation group was on the addition of Xuesaitong intravenous injection at the amount of 400mg/day. Observe and compare clinical treatment ef- ficiency and the incidence of complications in the two groups of. Results: The total efficiency of clinical treatment in the observe group was 96.0 %, while that in the control group was 80.0 %. In comparison between two groups, the efficiency of clinical treatment in the observe group was significantly higher than that in the control group, and the difference was statistically significant (P 〈0.05) ;1 case of complica- tions ocurred in the observation group,accounting for 2.0% ,while eight cases of complications ocurred in the control group,accounting for 16.0 %. In comparison between two groups, the incidence of complications in the observation group was significantly lower than the control group, and the difference was statistically significant (P 〈0.05). Conclnsions:The clinical use of Xuesaitong injection in treating acute hemorrhagic cerebrovascular disease had a better efficiency and fewer complications. It is worthy of further clinical application as its capability of significantly improving the condition and prognosis of the patients and their quality of life.
出处 《按摩与康复医学》 2012年第5期41-42,共2页 Chinese Manipulation and Rehabilitation Medicine
关键词 急性出血性脑血管 血塞通 并发症 Acute hemorrhagic cerebrovascular disease Xuesaitong Complication
  • 相关文献

参考文献6

二级参考文献20

共引文献15

同被引文献10

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部